Search research articles
Contact Us
Filters
Showing results (71-80 of 520) with videos related to
Page
of 52
Sort By:
Experientia
|
September 15, 1988
Evidence that the establishment of pregnancy requires activation of lipoxygenase and phospholipase-A2
P V Holmes, P Hellberg, P Sjöblom
The Lancet. Diabetes & Endocrinology
|
November 25, 2018
Research digest: genetics in cardiometabolic disease
Naveed Sattar, Michael V Holmes, David Preiss
Human Reproduction (Oxford, England)
|
August 1, 1991
Interleukin-1 alpha modulates luteinizing hormone stimulated cyclic AMP and progesterone release from human granulosa cells in vitro
A Sjögren, P V Holmes, T Hillensjö
Journal of the American College of Cardiology
|
February 2, 2019
Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week
Jane Armitage, Michael V Holmes, David Preiss
Journal of Virology
|
December 1, 1996
Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I
D B Tresnan, R Levis, K V Holmes
Plos One
|
October 8, 2013
Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation
Zhaohui Qian, Samuel R Dominguez, Kathryn V Holmes
The Lancet. Rheumatology
|
October 5, 2020
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19
Jonas Bovijn, Cecilia M Lindgren, Michael V Holmes
International Journal of Epidemiology
|
February 19, 2021
Commentary: Big data bring big controversies: HDL cholesterol and mortality
Mika Ala-Korpela, Sanna Kuusisto, Michael V Holmes
Endocrinology
|
June 1, 1986
The role of cyclic adenosine 3',5'-monophosphate in the ovulatory process of the in vitro perfused rabbit ovary
P V Holmes, L Hedin, P O Janson
The Lancet. Rheumatology
|
February 1, 2021
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply
Jonas Bovijn, Cecilia M Lindgren, Michael V Holmes
Page
of 52
Search research articles
Search
Showing results (71-80 of 520) with videos related to
Sort By:
Page
of 52
Experientia
|
September 15, 1988
Evidence that the establishment of pregnancy requires activation of lipoxygenase and phospholipase-A2
P V Holmes, P Hellberg, P Sjöblom
The Lancet. Diabetes & Endocrinology
|
November 25, 2018
Research digest: genetics in cardiometabolic disease
Naveed Sattar, Michael V Holmes, David Preiss
Human Reproduction (Oxford, England)
|
August 1, 1991
Interleukin-1 alpha modulates luteinizing hormone stimulated cyclic AMP and progesterone release from human granulosa cells in vitro
A Sjögren, P V Holmes, T Hillensjö
Journal of the American College of Cardiology
|
February 2, 2019
Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week
Jane Armitage, Michael V Holmes, David Preiss
Journal of Virology
|
December 1, 1996
Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I
D B Tresnan, R Levis, K V Holmes
Plos One
|
October 8, 2013
Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation
Zhaohui Qian, Samuel R Dominguez, Kathryn V Holmes
The Lancet. Rheumatology
|
October 5, 2020
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19
Jonas Bovijn, Cecilia M Lindgren, Michael V Holmes
International Journal of Epidemiology
|
February 19, 2021
Commentary: Big data bring big controversies: HDL cholesterol and mortality
Mika Ala-Korpela, Sanna Kuusisto, Michael V Holmes
Endocrinology
|
June 1, 1986
The role of cyclic adenosine 3',5'-monophosphate in the ovulatory process of the in vitro perfused rabbit ovary
P V Holmes, L Hedin, P O Janson
The Lancet. Rheumatology
|
February 1, 2021
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply
Jonas Bovijn, Cecilia M Lindgren, Michael V Holmes
Page
of 52